Loading data for MEDS — first visit, this takes a few seconds.
DataMEDS AI Inc. (MEDS)
NasdaqCM: MEDS
· Real-Time Price · USD
0.96
-0.21 (-17.95%)
At close: Aug 28, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
DataMEDS AI Inc. (MEDS) Stock Price, Analysis & Data
-17.95% (1D)
| Bid | 1.24 |
| Market Cap | 2.94M |
| Revenue (ttm) | 8.02M |
| Net Income (ttm) | -88.28M |
| n/a | |
| -48.3 | |
| n/a | |
| n/a | |
| P/B (ttm) | -0.14 |
| P/S (ttm) | 0.37 |
| Earnings Date | n/a |
| Ask | 1.25 |
| Volume | 128,475 |
| Avg. Volume (20D) | 142,019 |
| Open | 1.15 |
| Previous Close | 1.17 |
| Day's Range | 0.96 - 1.17 |
| 52-Week Range | 0.96 - 86.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MEDS
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a ph...
Industry Medical Distribution
Sector Healthcare
IPO Date Feb 21, 2025
Employees n/a
Stock Exchange NasdaqCM
Ticker Symbol MEDS
Website https://datamedsai.com
Financial Performance
In 2025, DataMEDS AI's revenue was 23.34M, an increase of 28.73% compared to the previous year's 18.13M. Earnings were -101.27M, an increase of 1,377.12%.
Financial Statements